Prime Medicine (NASDAQ:PRME) Azioni

PRIME MEDICINE INC

First Trust Heitman Global Prime Real Estate ETF

Prime Medicine

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Prime Medicine Inc

In a boost to Tesla Inc. and SpaceX CEO Elon Musk's Mars ambitions, President Donald Trump is seeking to involve private companies in Mars exploration.
What Happened: The White House&#8217;s 2026 budget proposal, unveiled on Friday, includes over $1 billion for Mars initiatives, according to a report <a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-wants-1-billion-for-private-sector-led-mars-exploration?srnd=homepage-americas">by</a> Bloomberg.
The budget outlines the creation of NASA&#8217;s Commercial Mars Payload Services Program (CMPS), which would grant contracts to companies working on spacesuits, communication systems, and a human-rated landing vehicle.
This initiative is part of a proposed $18.8 billion NASA budget, representing a 25% reduction from the previous year, significantly impacting the agency&#8217;s science portfolio.
The proposal builds on an earlier budget outline and is modelled after NASA&#8217;s Commercial Lunar Payload Services program, which has seen mixed success. SpaceX, led by Musk, is already developing a version of its Starship rocket for moon missions under NASA&#8217;s Artemis program.
See Also: <a href="https://benzinga.com/news/25/05/45681998/how-two-entrepreneurs-made-200-million-by-selling-mayonnaise-for-10-per-jar">How Two Entrepreneurs Made $200 Million By Selling Mayonnaise For $10 Per Jar</a>
Jared Isaacman, Trump&#8217;s nominee for NASA administrator, indicated that the agency could pursue lunar and Martian missions simultaneously. However, the proposed cuts to NASA&#8217;s science budget have drawn criticism from space industry figures and lawmakers, including former Republican Congressmen Newt Gingrich and Bob Walker.
Why It Matters: The proposed budget shift towards Mars exploration comes amidst significant changes at NASA. Earlier this month, it was reported that NASA is preparing for a <a href="https://www.benzinga.com/markets/25/05/45189017/nasa-prepares-for-6-billion-budget-cut-amid-shift-towards-elon-musks-mars-focused-initiatives">$6 billion budget cut</a>.
Meanwhile, <a href="https://www.benzinga.com/general/space/25/05/45636692/elon-musks-mars-ambitions-face-new-setback-as-spacex-starship-test-flight-fails">SpaceX&#8217;s recent Starship test flight</a> faced setbacks, highlighting the challenges in achieving Musk&#8217;s ambitious timeline for Mars missions. Musk has previously suggested that <a href="https://www.benzinga.com/25/03/44350440/elon-musk-confirms-starship-to-carry-tesla-optimus-to-mars-by-2026-predicts-human-landing-by-2029">human landings on Mars</a> could begin as early as 2029, though some experts, like former NASA astronaut José Hernández, believe<a href="https://www.benzinga.com/25/03/44373082/former-nasa-astronaut-predicts-mars-travel-still-15-years-away-not-5-years-as-elon-musk-alludes-to"> such travel is still 15 years away</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/topics/25/05/45708285/elon-musk-lobbies-for-support-from-lawmakers-on-legislation-for-self-driving-cars-report">Elon Musk Lobbies For Support From Lawmakers On Legislation For Self-Driving Cars: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Joey Sussman / Shutterstock.com

SPACE

President Trump Proposes $1 Billion For Private Sector Mars Exploration: Report

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk is actively lobbying U.S. lawmakers to establish a regulatory framework for autonomous vehicles.
Musk, alongside his team, has been directly contacting Congress members to rally support for this initiative, <a href="https://www.bloomberg.com/news/articles/2025-05-30/musk-lobbies-washington-to-clear-way-for-self-driving-cars">according</a> to a Bloomberg report.
In recent weeks, Musk has been involved in discussions about revising a bill introduced on May 15, which aims to establish a basic framework for autonomous vehicles.
The options under consideration include fast-tracking the bill or proposing a more comprehensive measure before the July 4 recess, according to sources familiar with the matter.
During a Friday press conference at the Oval Office, Musk confirmed his continued advisory role to President Donald Trump, despite stepping down from the Department of Government Efficiency. The White House deputy press secretary, Harrison Fields, emphasized that the administration&#8217;s policy is focused on achieving the president&#8217;s agenda.
See Also: <a href="https://benzinga.com/25/05/45666513/a-major-byd-dealer-in-china-shut-down-its-operations-as-ev-giant-expands-into-europe-report">Over 20 BYD Dealerships Shut Down In China Amid Expansion To Europe, Impacting 1,000+ Customers: Report</a>
Why It Matters: The push for federal support on autonomous vehicles is crucial as <a href="https://www.benzinga.com/tech/25/05/45662671/tesla-targets-june-12-for-robotaxi-launch-in-austin-elon-musk-says-company-ramped-up-fsd-testing-a-month-ahead-of-schedule">Tesla prepares to launch its Robotaxi service in Austin</a> on June 12. The company has accelerated its Full Self-Driving (FSD) testing, aiming to meet this deadline. However, the launch remains tentative, dependent on regulatory approvals.
Tesla also intends to introduce Cybercabs, pending federal approval for vehicles without steering wheels or pedals.
Analyst Dan Ives of Wedbush Securities views<a href="https://www.benzinga.com/25/05/45667224/dan-ives-calls-elon-musks-trump-white-house-exit-music-to-tesla-shareholders-ears-predicts-renewed-autonomous-vehicle-focushttps:/www.benzinga.com/tech/25/05/45535283/elon-musk-brushes-off-potential-tesla-uber-deal-believes-owners-could-add-their-cars-to-ev-giants-autonomous-fleet-instead"> Musk&#8217;s departure from a White House</a> role as a positive shift, allowing Musk to concentrate on Tesla&#8217;s autonomous vehicle ambitions. This renewed focus is seen as a promising development for shareholders.
Despite the enthusiasm, some industry experts, like Gary Black of Future Fund LLC,<a href="https://www.benzinga.com/25/05/45582499/gary-black-slams-teslas-unsupervised-autonomous-driving-ahead-of-austin-robotaxi-launch-i-have-warned"> express concerns over unsupervised autonomous driving</a>. Black has repeatedly cautioned investors about the risks associated with such technology, particularly as Tesla gears up for its upcoming launch.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/entrepreneurship/25/05/45705941/openai-secures-11-6b-for-texas-data-center-expansion-reducing-microsoft-dependence">OpenAI Secures $11.6B For Texas Data Center Expansion, Reducing Microsoft Dependence</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors
Photo courtesy: Ken Wolter / Shutterstock.com

Tech

TSLA

Elon Musk Lobbies For Support From Lawmakers On Legislation For Self-Driving Cars: Report

On Friday, a federal judge signaled he may scale back the Justice Department's proposed remedies for Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google's <a href="https://www.benzinga.com/government/24/08/40169996/alphabet-loses-antitrust-suit-over-google-search-dominance-report">alleged search monopoly</a>, citing the fast-changing role of artificial intelligence in online search.
What Happened: U.S. District Judge Amit Mehta, presiding over the high-profile antitrust case, expressed skepticism about imposing a 10-year oversight plan that would force Google to share search data and stop paying Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and others to be the default search engine, reported Reuters.
"Ten years may seem like a short period, but in this space, a lot can change in weeks," Mehta said, referring to ChatGPT-maker OpenAI's decision to buy Jony Ive's startup to <a href="https://www.benzinga.com/tech/25/05/45640879/openais-sam-altman-says-6-5b-deal-with-jony-ive-to-build-ai-companions-could-add-1-trillion-in-company-value-report">build AI devices</a>.&nbsp;
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/05/45486639/sundar-pichai-reveals-google-parent-once-super-intensely-debated-about-buying-netflix-in-a-world-of-butterfly-effects" target="_blank" rel="noreferrer noopener">Sundar Pichai Reveals Google-Parent Once Super Intensely Debated About Buying Netflix: ‘In A World Of Butterfly Effects…&#8217;</a>
He added that future competition may not come from <a href="https://www.benzinga.com/news/23/10/35102432/apples-dismissed-plan-to-replace-google-with-duckduckgo-on-safari-the-inside-story">traditional search rivals like</a> Microsoft Corp.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Bing or DuckDuckGo, but from AI companies offering fundamentally different user experiences.
"If anything, it's going to be one of these AI companies that can do more than just search. And Why? Because maybe people don't want 10 blue links anymore," Mehta said.
Google's lawyer John Schmidtlein pushed back on the idea of giving AI rivals access to Google's proprietary data, arguing, "Coming to Google and asking Google for a handout when they are the market leader seems completely disproportionate to what this case is about."
Previously, Nick Turley, OpenAI&#8217;s product head for ChatGPT, testified that the AI startup would be open to acquiring Chrome if Google <a href="https://www.benzinga.com/news/legal/25/04/44941262/openai-once-tried-to-use-googles-search-technology-instead-of-microsoft-bing-due-to-quality-issues-was-rejected-now-sam-altmans-startup-says-itd-buy-chrome-if-forced-antitrust-sale-happens">were ever compelled to sell it</a>.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It's Important: Earlier this month, Apple executive Eddy Cue testified that Safari had seen a <a href="https://www.benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-waiting-for-data-and-start-fighting-models-like-chatgpt">drop in search volumes</a> for the first time in over 20 years, attributing the decline to the growing use of AI-powered searches.
Alphabet CEO Sundar Pichai pushed back on this in an interview with The Verge published this week, asserting that the <a href="https://www.benzinga.com/media/25/05/45687166/apple-may-see-fewer-searches-in-safari-but-google-ceo-sundar-pichai-insists-ai-is-fueling-overall-query-growth-far-from-a-zero-sum-game">data does not indicate a decline</a> in overall activity. &#8220;We&#8217;ve been very clear. We&#8217;re seeing overall query growth in search,&#8221; he said.
During his testimony, Cue also revealed that Apple is actively <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45259675/apple-alphabet-shares-tumble-amid-potential-ai-search-shift">considering integrating</a> an AI-driven search engine into Safari, evaluating potential partnerships with OpenAI, Anthropic and Perplexity AI.
Meanwhile, Google <a href="https://www.benzinga.com/markets/25/05/45537306/google-unveils-total-reimagining-of-search-with-chatbot-style-feature-to-compete-with-openai">introduced a new &#8220;AI mode&#8221;</a> in its Search and Chrome browser during its developer conference. Now available to all U.S. users, the feature offers a conversational, Q&amp;A-style interface similar to ChatGPT, replacing the traditional list of search result links.
Price Action: Alphabet Inc.&#8217;s Class A shares dipped 0.32% in after-hours trading, with Class C shares also down 0.32%, based on <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
According to Benzinga Edge Stock Rankings, Alphabet holds a growth score of 88.54%. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here to compare it with other companies</a> like Apple.
<figure class="wp-block-image aligncenter size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30220506/Screenshot-2025-05-31-at-7.33.05%E2%80%AFAM.png" alt="" class="wp-image-933903" /></a></figure>
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/04/45090992/mark-zuckerberg-warns-of-serious-disadvantage-as-chinas-data-center-blitz-could-let-deepseek-leapfrog-us-ai-labs" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Warns Of ‘Serious Disadvantage' As China's Data-Center Blitz Could Let DeepSeek Leapfrog US AI Labs</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: JHVEPhoto / Shutterstock.com

AAPL

GOOG

GOOGL

MSFT

Google's Monopoly Case Takes A Turn As Judge Considers Lighter Remedies Amid Rising Competition From AI Rivals Like OpenAI And Perplexity

DoorDash (NASDAQ:<a href="https://www.benzinga.com/quote/DASH"> DASH</a>) is synonymous with food delivery in the U.S., and now it appears the company is positioning itself to take on the European market.The delivery giant has <a href="https://ir.doordash.com/news/news-details/2025/DoorDash-Announces-Agreement-to-Acquire-Deliveroo/default.aspx">announced</a> it will acquire U.K.-based Deliveroo in a $3.9 billion deal. U.K.-based Deliveroo is like DoorDash in that it is one of the most recognizable names in its geographic market.&nbsp;
The deal, which <a href="https://www.reuters.com/markets/deals/doordash-acquire-uks-deliveroo-39-billion-deal-2025-05-06/">Reuters</a> says both sides have been working on for the last several months, is indicative of a changing landscape in the food delivery business. According to Reuters, the sector has been struggling due to several factors. First, inflation and increased costs have forced consumers to tighten their belts, and dialing back on luxuries like dinner delivery is an easy way to cut expenses. Second, there is an overabundance of competitors in the sector.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
The two obstacles to profit have created an environment where consolidation is much more likely. AJ Bell Investment Director Russ Mould told Reuters he believes the entire sector has been weakened by an oversaturation of delivery services competing for the same customers. That kind of climate inevitably means that some food-delivery services operating today will not survive the current downturn.
&#8220;Only the strongest will survive, and they&#8217;re the ones picking up smaller rivals who realize their future is [the] best part of a bigger entity, and not going it alone,&#8221; he said.&nbsp;
<a href="https://www.benzinga.com/general/restaurants/25/05/45400599/only-reasonable-profits-jdcom-takes-aim-at-global-food-delivery-economics-with-zero-commission-modelrevives-founders-035-principle">DoorDash</a> may have gotten a good deal on the final price. According to Reuters, Deliveroo shares are trading on the London Stock Exchange for less than half of their 2021<a href="https://www.benzinga.com/money/how-to-invest-in-upcoming-ipos"> IPO</a> price. Deliveroo CEO Will Shu, who delivered meals himself during the company's formative years, was philosophical about the current business climate and its effect on the company's share price.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
&#8220;That was a different time, (and) a different interest rate environment," Shu told Reuters. He was optimistic about Deliveroo's long-term future, but also very aware of how much competition his company was facing. &#8220;The board and myself evaluated that and said, &#8216;Where do we think Deliveroo should be in order for us to truly win?&#8217; And we thought this was the right place for us,&#8221; he said.
Shu's analysis illustrates the reality of being a CEO of a company. You have a duty to your shareholders and investors to do what's best for the company, even if that means being acquired at a relative discount by a larger company. With that said, it's not all bad news for Shu. Reuters estimates that he will receive roughly $215 million for his Deliveroo shares.&nbsp;
"I could not be more excited by the prospect of what DoorDash and Deliveroo will be able to accomplish together," said <a href="https://ir.doordash.com/news/news-details/2025/DoorDash-Announces-Agreement-to-Acquire-Deliveroo/default.aspx">DoorDash CEO</a> Tony Xu. " We'll cover more than 40 countries with a combined population of more than 1 billion people, enabling us to provide more local businesses with the tools and technology they need to thrive." Reuters estimates the two companies did roughly $90 billion in delivery orders in 2024.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li><a href="https://www.benzinga.com/money/overplay">Mark Cuban Backs This Innovative Startup That Turns Videos into Games  &#8212; Claim Your Share Now</a></li>
</ul>
Image: Shutterstock

News

Is DoorDash Planning To Gobble Up Europe? Company Strikes $3.9 Billion Deal To Buy UK Food Delivery Company Deliveroo

EKSO

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

LYEL

APDN

Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) has outperformed the market over the past 15 years by 3.91% on an annualized basis producing an average annual return of 16.06%. Currently, Cigna Group has a market capitalization of $85.84 billion. 
Buying $100 In CI: If an investor had bought $100 of CI stock 15 years ago, it would be worth $929.38 today based on a price of $316.64 for CI at the time of writing.
<h3>Cigna Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748648720_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today

If you've ever assumed retirement meant having a seven-figure nest egg, you're in good company — and maybe a little stressed.
For years, Americans have treated the $1 million mark as the gold standard for retiring comfortably. Anything less? Cue the panic attacks.
But according to Northwestern Mutual's just-released <a href="https://news.northwesternmutual.com/planning-and-progress-study-2025">2025 Planning &amp; Progress Study</a>, the average American now believes they need $1.26 million tucked away to retire in peace. That's actually down from $1.46 million last year.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Sure, the so-called magic number dropped by $200,000, but don't pop the champagne just yet. According to the same study, most Americans are <a href="https://www.benzinga.com/personal-finance/25/02/43856927/billionaire-blackrock-ceo-larry-fink-says-people-are-saving-too-much-and-not-investing-enough-to-retire-with-dignity">still wildly unprepared</a>. More than half – 51% – say it's somewhat or very likely they'll outlive their savings. Only 16% feel confident that outliving their savings is "very unlikely."&nbsp;&nbsp;
So if your retirement plan is "hope for the best," you're not alone.
The ‘magic number' to retire comfortably may be down this year, but it's still far beyond what many people actually have. And the gap isn't just wide — it's a canyon.&nbsp;
<a href="https://institutional.vanguard.com/insights-and-research/report/how-america-saves.html?cmpgn=IIG:TL:HAS:HAS24:SRCH:PS:XX:TL:GG:Unknown:Phrase:TLEAD:20230615:BD:NONE:NONE:KW:401kGeneral&amp;gclsrc=aw.ds&amp;gad_source=1&amp;gad_campaignid=17413933089&amp;gbraid=0AAAAADyd_RXD2epePnTlHlLRHWErHyW3U">Vanguard's 2024 report</a> puts the average 401(k) balance across all age groups at just $134,128. That's barely a tenth of what Americans say they'll need to retire comfortably.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
And what's behind the drop? Inflation is still top of mind, but it's cooled off—dropping from around 6% in 2023 to <a href="https://www.bls.gov/opub/ted/2025/the-consumer-price-index-rose-3-0-percent-from-january-2024-to-january-2025.htm">about 3% in 2024</a>. That doesn't mean prices are falling; it just means they're not rising quite as fast. Groceries still feel like a splurge and rent still makes you cry, but apparently, that slight dip was enough for Americans to shave down their expectations.
Either way, the new target still feels like a stretch. <a href="https://www.benzinga.com/money/smartasset">One in four Americans has just a single year of income saved</a>. Among Gen X'ers, 52% have saved up to three times their annual income, but&nbsp; 54% don't think they'll be financially ready to retire when the time comes.<a href="https://www.asppa-net.org/news/2025/4/magic-number-for-retirement-drops-with-inflation/">&nbsp;</a>
Which raises a fair question—not from a study or expert, just plain observation: Are Americans adjusting the number because they think they can genuinely live on less, or have they just accepted that $1.26 million sounds more reachable than $1.46 million? Maybe this is optimism. Maybe it's financial fatigue.&nbsp;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
If you're wondering how anyone hits that $1.26 million target: you either start young or start wealthy. To get there by age 65, a 20-year-old would need to sock away $330 a month at a 7% return. <a href="https://www.benzinga.com/personal-finance/24/08/40295808/youre-40-50-or-60-do-you-know-how-much-you-should-have-saved-for-retirement-by-now">Wait until you're 50? </a>That jumps to a casual $3,958 per month.<a href="https://www.asppa-net.org/news/2025/4/magic-number-for-retirement-drops-with-inflation/">&nbsp;</a>
Yes, the goal dipped—but the struggle to reach it hasn't. Americans may be adjusting expectations, but most still have a long way to go before <a href="https://www.benzinga.com/money/are-you-rich">retirement feels anything close to "comfortable."</a>
Read Next:
<ul class="wp-block-list">
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Can You Guess What Americans Think They Need To Retire Comfortably? Hint: The 'Magic Number' Just Dropped From Last Year

<ul class="wp-block-list">
<li>The U.S. Department of Health and Human Services says that around 57% of Americans will need long-term care at some point</li>
<li>Most households have grossly underestimated the potential cost of that long-term care, and aren't aware that they will have to pay out of pocket for much of it</li>
<li>The total cost of long-term care can be significant, extending beyond $100,000</li>
</ul>
Long-term care costs can be significant, extending well beyond $100,000, but experts tell <a href="https://www.cnbc.com/2025/05/17/why-long-term-care-costs-can-be-a-huge-problem.html">CNBC</a> that most households aren't prepared to handle the expense.
"People don't plan for it in advance," certified financial planner Carolyn McClanahan told the network. "It's a huge problem."
A 2022 <a href="https://www.urban.org/research/publication/long-term-services-and-supports-older-americans">report</a> by the U.S. Department of Health and Human Services and the Urban Institute says that 57% of Americans turning 65 will develop a disability that is serious enough to require long-term care. The average cost of this long-term care is $122,400, the report said.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
On average, families will pay for 37% of the total cost of this long-term care out of pocket, with the rest covered by insurance and public programs.&nbsp;
"It's pretty clear [workers] don't have that amount of savings in retirement, that amount of savings in their checking or savings accounts, and the majority don't have long-term care insurance," Employee Benefit Research Institute strategist Bridget Bearden told CNBC. "So where is the money going to come from?"
Costs for long-term care vary widely, depending on where you live. However, <a href="https://www.carescout.com/cost-of-care">data</a> collected by Genworth and CareScout put the national average for a home health aide at $6,483 per month and $5,900 for a spot in an assisted living facility.&nbsp;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
Still, many people grossly underestimate how much long-term care could potentially cost them. A recent Employee Benefit Research Institute <a href="https://www.ebri.org/health/content/employee-perspectives-on-long-term-care">report</a> found that "a significant proportion of future caregivers had not estimated LTC costs," and those who had expected them to remain under $50,000. Additionally, the report found that 43% of future caregivers expected Medicare to cover the costs of long-term care, and 29% expected Medicaid to foot the bill.
Experts told CNBC that estimates like these are not realistic. Health insurance generally doesn't cover long-term care services, and Medicare only covers select aspects, they say.
McClanahan told CNBC that Medicare typically covers skilled care for up to 100 days, which covers things like rehab or medicine administration, but will not cover the custodial care required for daily activities like bathing and dressing.&nbsp;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
As for Medicaid, the largest payer of long-term care costs, not everyone will qualify. Most people who are eligible for these benefits come from low-income households. "You basically have to be destitute" for Medicaid to kick in, she said.
"The challenge with long-term care costs is they're unpredictable," McClanahan told CNBC. "You don't always know when you'll get sick and need care."&nbsp;
She advises Gen Xers and Millennials to begin planning for potential long-term care needs now. "When you think through it in advance, it keeps the decisions way more level-headed," she said.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

'It's A Huge Problem,' Experts Urge Gen Xers And Millennials To Plan For Long-Term Care

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 5 years by 9.52% on an annualized basis producing an average annual return of 23.37%. Currently, Intuitive Surgical has a market capitalization of $197.97 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 5 years ago, it would be worth $288.38 today based on a price of $552.34 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748647811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ISRG

$100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today

NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has outperformed the market over the past 15 years by 38.55% on an annualized basis producing an average annual return of 50.71%. Currently, NVIDIA has a market capitalization of $3.29 trillion. 
Buying $100 In NVDA: If an investor had bought $100 of NVDA stock 15 years ago, it would be worth $44,689.54 today based on a price of $134.77 for NVDA at the time of writing.
<h3>NVIDIA's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748646912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NVDA

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) has outperformed the market over the past 5 years by 51.3% on an annualized basis producing an average annual return of 65.16%. Currently, Comfort Systems USA has a market capitalization of $16.87 billion. 
Buying $100 In FIX: If an investor had bought $100 of FIX stock 5 years ago, it would be worth $1,256.85 today based on a price of $478.23 for FIX at the time of writing.
<h3>Comfort Systems USA's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748646010_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Comfort Systems USA 5 Years Ago Would Be Worth Today

IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) has outperformed the market over the past 5 years by 47.83% on an annualized basis producing an average annual return of 61.68%. Currently, IES Hldgs has a market capitalization of $5.16 billion. 
Buying $100 In IESC: If an investor had bought $100 of IESC stock 5 years ago, it would be worth $1,103.53 today based on a price of $259.66 for IESC at the time of writing.
<h3>IES Hldgs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748645112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IESC

$100 Invested In IES Hldgs 5 Years Ago Would Be Worth This Much Today

STLD

UPDATE: President Donald Trump Says He Would Be Increasing Tariffs On Steel To 50% From 25%; Tariffs To Go Into Effect Next Week

<a href="https://www.youtube.com/watch?v=xqnyP6mUI7w">https://www.youtube.com/watch?v=xqnyP6mUI7w</a>

General

President Trump Says U.S. Steel Will Be Controlled By USA; Says Steel Tariffs Go Into Effect Next Week

<a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true</a>

'Trump to Raise Steel Tariffs to 50% to Help Nippon-US Steel Deal'- Bloomberg

In the current market session, Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) share price is at $77.89, after a 0.84% drop. Over the past month, the stock spiked by 1.38%, but over the past year, it actually fell by 3.53%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1748642422_0.png" alt="Past Year Chart" />

<h3>Principal Financial Group P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Principal Financial Group has a better P/E ratio of 16.82 than the aggregate P/E ratio of 13.53 of the Insurance industry. Ideally, one might believe that Principal Financial Group Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748642422_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Principal Financial Group

Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) has outperformed the market over the past 20 years by 1.42% on an annualized basis producing an average annual return of 9.7%. Currently, Constellation Brands has a market capitalization of $31.79 billion. 
Buying $100 In STZ: If an investor had bought $100 of STZ stock 20 years ago, it would be worth $634.94 today based on a price of $178.58 for STZ at the time of writing.
<h3>Constellation Brands's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748642418_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-officials-set-for-talks-with-asia-leaders-on-alaska-energy?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/trump-officials-set-for-talks-with-asia-leaders-on-alaska-energy?embedded-checkout=true</a>

'Trump Officials Set for Talks With Asia Leaders on Alaska Energy'- Bloomberg

Earnings

Press Releases

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

Health Care

Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

Management

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

Comments

Prime Medicine

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO